REFRACTORY
Clinical trials for REFRACTORY explained in plain language.
Never miss a new study
Get alerted when new REFRACTORY trials appear
Sign up with your email to follow new studies for REFRACTORY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Gentler myeloma combo aims to help frail patients fight relapse
Disease control OngoingThis study tests a three-drug combination (isatuximab, pomalidomide, and dexamethasone) at lower-than-standard doses in people with multiple myeloma that has returned or not responded to treatment. The goal is to see if the lower doses are both safe and effective for patients who…
Matched conditions: REFRACTORY
Phase: PHASE2 • Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Disease control
Last updated May 17, 2026 05:32 UTC
-
Armored immune cells take on tough blood cancers in early trial
Disease control OngoingThis early-phase study tests a new type of immune cell therapy for people with certain blood cancers (like CLL) that have not responded to standard treatments. The cells are taken from the patient, modified with an 'armor' to make them stronger, and then given back. The main goal…
Matched conditions: REFRACTORY
Phase: PHASE1 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated May 17, 2026 05:29 UTC